861 related articles for article (PubMed ID: 16273122)
1. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
Ridley DL; Rogers A; Wonnacott S
Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514
[TBL] [Abstract][Full Text] [Related]
3. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
Marks MJ; Whiteaker P; Collins AC
Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine.
Sokolova E; Matteoni C; Nistri A
Br J Pharmacol; 2005 Dec; 146(8):1087-95. PubMed ID: 16230999
[TBL] [Abstract][Full Text] [Related]
6. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
de Moura FB; McMahon LR
Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600
[TBL] [Abstract][Full Text] [Related]
7. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
[TBL] [Abstract][Full Text] [Related]
8. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line.
Peng JH; Lucero L; Fryer J; Herl J; Leonard SS; Lukas RJ
Brain Res; 1999 Apr; 825(1-2):172-9. PubMed ID: 10216184
[TBL] [Abstract][Full Text] [Related]
9. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release.
Ohtani M; Oka T; Badyuk M; Xiao Y; Kellar KJ; Daly JW
Mol Pharmacol; 2006 Mar; 69(3):899-907. PubMed ID: 16332988
[TBL] [Abstract][Full Text] [Related]
10. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
11. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
13. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
Meyers EE; Loetz EC; Marks MJ
Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
[TBL] [Abstract][Full Text] [Related]
16. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.
Braida D; Ponzoni L; Martucci R; Sparatore F; Gotti C; Sala M
Psychopharmacology (Berl); 2014 May; 231(9):1975-85. PubMed ID: 24311357
[TBL] [Abstract][Full Text] [Related]
17. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes.
Genzen JR; Van Cleve W; McGehee DS
J Neurophysiol; 2001 Oct; 86(4):1773-82. PubMed ID: 11600638
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands.
Molinari EJ; Delbono O; Messi ML; Renganathan M; Arneric SP; Sullivan JP; Gopalakrishnan M
Eur J Pharmacol; 1998 Apr; 347(1):131-9. PubMed ID: 9650859
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
